Suchergebnisse - "Yi, Zongbi"

PubPharm (9)

1

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients

enthalten in: Cancer medicine | 2022

von Liu, B. | Yi, Z. | Guan, Y. | +10

2

The molecular tumor burden index as a response evaluation criterion in breast cancer

enthalten in: Signal transduction and targeted therapy | 2021

von Yi, Z. | Ma, F. | Rong, G. | +10

3

Mutational characteristics determined using circulating tumor DNA analysis in triple-negative breast cancer patients with distant metastasis

enthalten in: Cancer communications (London, England) | 2020

von Rong, G. | Yi, Z. | Ma, F. | +4

4

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Yi, Z. | Liu, B. | Sun, X. | +10

5

Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China

enthalten in: Cancer communications (London, England) | 2020

von Yi, Z. | Ma, F. | Rong, G. | +3

6

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

enthalten in: International journal of cancer | 2020

von Ma, F. | Guan, Y. | Yi, Z. | +16

ErratumIn: Int J Cancer. 2020 Jun 15;146(12):E8. - PMID 32320496

7

Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Guan, X. | Liu, B. | Niu, Y. | +9

8

Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis

enthalten in: Scientific reports | 2017

von Yi, Z. | Ma, F. | Li, C. | +9

9

ctDNA dynamics : a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy

enthalten in: Oncotarget | 2016

von Ma, F. | Zhu, W. | Guan, Y. | +9

1
[1]